Article Text
Abstract
Rapid, safe and effective arterial recanalisation to restore blood flow and improve functional outcome remains the primary goal of hyperacute ischaemic stroke management. The benefit of intravenous thrombolysis with recombinant tissue-type plasminogen activator for patients with severe stroke due to large artery occlusion is limited; early recanalisation is generally less than 30% for carotid, proximal middle cerebral artery or basilar artery occlusion. Since November 2014, nine positive randomised controlled trials of mechanical thrombectomy for large vessel occlusion in the anterior circulation have led to a revolution in the care of patients with acute ischaemic stroke. Its efficacy is unmatched by any previous therapy in stroke medicine, with a number needed to treat of less than 3 for improved functional outcome. With effectiveness shown beyond any reasonable doubt, the key challenge now is how to implement accessible, safe and effective mechanical thrombectomy services. This review aims to provide neurologists and other stroke physicians with a summary of the evidence base, a discussion of practical aspects of delivering the treatment and future challenges. We aim to give guidance on some of the areas not clearly described in the clinical trials (based on evidence where available, but if not, on our own experience and practice) and highlight areas of uncertainty requiring further research.
- stroke
- thrombolysis
- mechanical
- thrombectomy
This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/
Statistics from Altmetric.com
Footnotes
Contributors ME, PC, PW and DW wrote the manuscript and are responsible for the content.
Funding DW receives research funding support from the British Heart Foundation and the Stroke Association (TSA BHF 2009/01; PPA 2015/04). This work was undertaken at University College London Hospitals NHS Foundation Trust/University College London who received a proportion of funding from the Department of Health’s National Institute for Health Research Biomedical Research Centers funding scheme.
Competing interests None declared.
Provenance and peer review Commissioned; externally peer reviewed. This paper was reviewed by William Whiteley, Edinburgh, UK.
Linked Articles
- Editors' commentary
- Editorial
Other content recommended for you
- Predicting mortality in acute ischaemic stroke treated with mechanical thrombectomy: analysis of a multicentre prospective registry
- Mechanical thrombectomy versus systemic thrombolysis in MCA stroke: a distance to thrombus-based outcome analysis
- Predictors of poor clinical outcome despite complete reperfusion in acute ischemic stroke patients
- Mechanical thrombectomy of M1 and M2 middle cerebral artery occlusions
- Time to redefine success? TICI 3 versus TICI 2b recanalization in middle cerebral artery occlusion treated with thrombectomy
- Advances in mechanical thrombectomy for acute ischaemic stroke from large vessel occlusions
- Increased middle cerebral artery mean blood flow velocity index after stroke thrombectomy indicates increased risk for intracranial hemorrhage
- Haemorrhage after thrombectomy with adjuvant thrombolysis in unknown onset stroke depends on high early lesion water uptake
- Rescue intracranial permanent stenting for refractory occlusion following thrombectomy: a propensity matched analysis
- Predictors and impact of hemorrhagic transformations after endovascular thrombectomy in patients with acute large vessel occlusions